A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants

Recruiting now · Phase 1

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to evaluate novel KarX and KarT prototypes versus the KarXT and KarX-EC reference following single doses, and to explore the effect of food after multiple doses of selected prototypes in healthy adult participants.

Key facts

Study ID

NCT07063342

Run by

Bristol-Myers Squibb

People needed

72

Starts

2025-06-27

Expected to finish

2027-03-29

Last updated by the study team

2026-07-09

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI between 18.0 kg/m2 to 32.0 kg/m2, inclusive, at screening.
• Other protocol-defined Inclusion/Exclusion criteria apply.

Where it is running

• Quotient Sciences — Nottingham, Nottinghamshire, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.